article thumbnail

Navigating the rapidly changing oncology treatment landscape: how digital tools can help

Impetus Digital

In 2022, global spending on cancer medicines was approximately 196 billion USD, and this number is forecasted to reach $375 billion by 2027. In turn, these insights can be used as a basis for digital education initiatives for other healthcare providers and patients on the currently available treatment choices and therapies in development.

article thumbnail

9 Steps to Build Digital Healthcare Solutions that Meet Patient’s Growing Expectations

PM360

Patients now demand greater access to their health information, desire more communication with their healthcare providers, and seek personalized care tailored to their individual needs. Patients increasingly expect a seamless healthcare experience in which all their health information is integrated and easily accessible.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Benefits and Challenges of Telehealth to Consider in Healthcare

Medico Reach

However, over 95% of healthcare providers use this technology after the global viral outbreak. Adopting this technology can offer numerous benefits to healthcare companies and professionals. Hence, organizations can utilize cost savings to plan more effective healthcare marketing campaigns. Benefits of Telehealth.

article thumbnail

4 Ways to Meet the Needs of an Increasing Health-conscious Audience

PM360

What if you scan a QR code on the box or bottle and it would trigger an approval from your healthcare provider? Healthcare has been expanding beyond the walls of traditional health systems for years, and this change has only been accelerated by COVID-19. Additionally, Walgreens Boots Alliance (WBA) has made a $5.2

Retail 97
article thumbnail

How retailers and “payviders” are disrupting U.S. healthcare in 2024

Clarivate

The downsizing is not a total reversal of Walgreens’ aggressive primary-care clinic expansion plan (which in 2021 imagined 1,000 VillageMD clinics by 2027), but rather a reallocation of capital to increase VillageMD’s density in “high-opportunity” markets—i.e., those with high patient volumes.

Retail 52
article thumbnail

Making Sense of the Latest Changes to the Market Access Landscape

PM360

However, Medicare will only be able to negotiate prices for 10 Part D drugs in 2026, another 15 Part D drugs in 2027, another 15 Part D and Part B drugs in 2028, and another 20 Part D and Part B drugs for 2029 and subsequent years.

article thumbnail

Specialty Treatments Require a New Approach to Affordability

PM360

aging population, a rise in the net per capita spending on specialty drugs, an increased life expectancy (apart from the impact of COVID), and the increasing prevalence of chronic diseases are expected to boost the specialty pharmaceuticals market to $352 billion by 2027. The Uses—and Costs—of Specialty Treatments Keep Rising A U.S.